BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 63 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,197,000 | -36.4% | 3,287,000 | -35.6% | 0.00% | -33.3% |
Q2 2023 | $5,024,695 | +19.1% | 5,107,000 | +24.3% | 0.01% | +20.0% |
Q1 2023 | $4,217,427 | -10.7% | 4,107,000 | -7.5% | 0.01% | 0.0% |
Q4 2022 | $4,724,000 | +81.3% | 4,442,000 | +69.4% | 0.01% | +66.7% |
Q3 2022 | $2,605,000 | -43.7% | 2,622,000 | -43.8% | 0.00% | -50.0% |
Q2 2022 | $4,625,000 | -1.2% | 4,667,000 | 0.0% | 0.01% | +50.0% |
Q1 2022 | $4,682,000 | -25.4% | 4,667,000 | -22.0% | 0.00% | -20.0% |
Q4 2021 | $6,280,000 | -1.7% | 5,982,000 | -3.5% | 0.01% | 0.0% |
Q3 2021 | $6,388,000 | -13.2% | 6,199,000 | -12.4% | 0.01% | -16.7% |
Q2 2021 | $7,361,000 | +0.5% | 7,078,000 | -1.5% | 0.01% | -40.0% |
Q1 2021 | $7,326,000 | +1.0% | 7,188,000 | +6.4% | 0.01% | -9.1% |
Q4 2020 | $7,256,000 | -14.5% | 6,753,000 | -16.3% | 0.01% | -21.4% |
Q3 2020 | $8,484,000 | -37.7% | 8,067,000 | -27.3% | 0.01% | -39.1% |
Q2 2020 | $13,609,000 | +58.6% | 11,101,000 | +35.6% | 0.02% | +27.8% |
Q1 2020 | $8,583,000 | +42.3% | 8,187,000 | -8.2% | 0.02% | +100.0% |
Q4 2019 | $6,032,000 | +89.6% | 8,915,000 | +176.9% | 0.01% | +80.0% |
Q3 2019 | $3,181,000 | +318000.0% | 3,220,000 | -57.9% | 0.01% | – |
Q2 2019 | $1,000 | 0.0% | 7,650,000 | +200.0% | 0.00% | – |
Q1 2019 | $1,000 | -100.0% | 2,550,000 | -15.0% | 0.00% | -100.0% |
Q4 2018 | $2,986,000 | -6.1% | 3,000,000 | 0.0% | 0.01% | +20.0% |
Q3 2018 | $3,179,000 | +4.2% | 3,000,000 | 0.0% | 0.01% | 0.0% |
Q2 2018 | $3,050,000 | +8.1% | 3,000,000 | 0.0% | 0.01% | 0.0% |
Q1 2018 | $2,822,000 | -5.9% | 3,000,000 | 0.0% | 0.01% | 0.0% |
Q4 2017 | $2,999,000 | +47.7% | 3,000,000 | +50.0% | 0.01% | +25.0% |
Q3 2017 | $2,031,000 | – | 2,000,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SHENKMAN CAPITAL MANAGEMENT INC | 30,138,000 | $29,510,000 | 3.72% |
PFM Health Sciences, LP | 45,910,000 | $46,002,000 | 1.72% |
Cheyne Capital Management (UK) LLP | 2,320,000 | $2,330,000 | 1.47% |
ADVENT CAPITAL MANAGEMENT /DE/ | 41,077,000 | $41,277,000 | 0.66% |
SSI INVESTMENT MANAGEMENT LLC | 9,071,000 | $9,068,000 | 0.50% |
PALISADE CAPITAL MANAGEMENT, LP | 14,548,000 | $14,612,000 | 0.34% |
RWC Asset Management LLP | 7,500,000 | $7,552,000 | 0.21% |
KBC Group NV | 400,000 | $40,316,000 | 0.15% |
PROSPECTOR PARTNERS LLC | 1,000,000 | $1,000,000 | 0.12% |
MACKAY SHIELDS LLC | 11,822,000 | $11,816,000 | 0.10% |